News
Clinical Trials Arena on MSN22h
Cognition announces outcomes from trial of zervimesine for geographic atrophyCognition Therapeutics has announced positive topline outcomes from the double-masked Phase II MAGNIFY trial of zervimesine ...
Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback